Tuberculosis

Tuberculosis (TB) is both preventable and curable, yet remains the world’s deadliest infectious disease. Although Canada is a low TB incidence country, TB continues to disproportionately affect First Nations, Inuit, and Métis peoples, and immigrant, refugee, and newcomer populations.

Tuberculosis (TB) Journey in Northern First Nations Communities

A Social Determinants and the TB Journey video.

The TB Journey Map for Northern First Nations Communities is an educational resource for services providers in TB-affected First Nations communities. It visually depicts the key stages in a typical patient journey with emphasis on the different health-care related, social and First Nations determinants of health.

Multi-Drug Resistant Tuberculosis – International Resources for Canadian Public Health Personnel

COMMENTARY: Yoav Keynan, MD and NCCID’s Scientific Lead COMMENT According to the WHO 2017 report, in 2016 globally, there were 600,000 new cases of tuberculosis with resistance to rifampicin, the most effective first-line drug, of which 490,000 cases had multidrug-resistant TB (MDR-TB), defined as resistance to rifampicin and isoniazid. Almost half (47%) of these cases…

IQ13: Post-landing Surveillance and Virtual Tuberculosis Services in Alberta

In this, the fifth in our ‘TB Talk’ series of episodes, we hear from Dr. Ryan Cooper, an infectious diseases specialist with Alberta Health Services. Here, Dr. Cooper speaks to how post-landing TB surveillance works in Canada (including some Alberta-specific challenges), plus the best approach to on-going follow-up. He also discusses how Alberta’s virtual TB clinic model has made a difference to rural, remote and Indigenous communities.

IQ12 : New Digital Technologies in TB

The fourth in our ‘TB Talk’ series, conversations from the most recent meeting of the North American Region of the International Union Against Tuberculosis. This episode, we hear from Dr. Dennis Falzon, a Medical Officer with the Stop TB Department at the World Health Organization in Geneva. Here, he discusses the WHO’s End TB Strategy, as well as the potential of new technologies to prevent and eliminate TB.